| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 41 | 42 | |
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 47 | 43 | |
| 2006 | Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1] | Chen C.-Y.; LIANG-IN LIN ; JIH-LUH TANG ; Tsay W.; HSIU-HAO CHANG ; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; MING YAO ; BOR-SHENG KO ; YAO-CHANG CHEN ; Lin K.-H.; Lin D.-T.; HWEI-FANG TIEN | Leukemia | 35 | 36 | |
| 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen C.-Y.; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; Tsay W.; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 50 | 47 | |
| 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen C.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; Tsay W.; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 265 | 246 | |
| 2013 | Antidiabetic effects of pterosin A, a small-molecular-weight natural product, on diabetic mouse models | Hsu F.-L.; Huang C.-F.; Chen Y.-W.; Yen Y.-P.; Wu C.-T.; Uang B.-J.; RONG-SEN YANG ; Liu S.-H. | Diabetes | 55 | 49 | |
| 2000 | ARL4, an ARF-like protein that is developmentally regulated and localized to nuclei and nucleoli | Lin C.-Y.; PEI-HSIN HUANG ; Liao W.-L.; Cheng H.-J.; Huang C.-F.; Kuo J.-C.; Patton W.A.; Massenburg D.; Moss J.; Fang-Jen Scott Lee | Journal of Biological Chemistry | 42 | 41 | |
| 2020 | Arl4D-EB1 interaction promotes centrosomal recruitment of EB1 and microtubule growth | Lin S.-J.; Huang C.-F.; Wu T.-S.; Li C.-C.; Fang-Jen Scott Lee | Molecular Biology of the Cell | 2 | 2 | |
| 2015 | Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice | Huang C.-F.; CHING-YAO YANG ; DING-CHENG CHAN ; CHING-CHIA WANG ; KUO-HOW HUANG ; Wu C.-C.; KEH-SUNG TSAI ; RONG-SEN YANG ; Liu S.-H. | Environmental Health Perspectives | 48 | 45 | |
| 2012 | Arsenic induces apoptosis in myoblasts through a reactive oxygen species-induced endoplasmic reticulum stress and mitochondrial dysfunction pathway | Yen Y.-P.; KEH-SUNG TSAI ; Chen Y.-W.; Huang C.-F.; RONG-SEN YANG ; Liu S.-H. | Archives of Toxicology | 129 | 118 | |
| 2021 | Arsenic induces autophagy-dependent apoptosis via Akt inactivation and AMPK activation signaling pathways leading to neuronal cell death | Fu S.-C.; Lin J.-W.; Liu J.-M.; SHING-HWA LIU ; Fang K.-M.; Su C.-C.; Hsu R.-J.; Wu C.-C.; Huang C.-F.; Lee K.-I.; Chen Y.-W. | NeuroToxicology | 9 | 7 | |
| 2011 | Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways | Lu T.-H.; Su C.-C.; Chen Y.-W.; CHING-YAO YANG ; Wu C.-C.; Hung D.-Z.; Chen C.-H.; Cheng P.-W.; Liu S.-H.; Huang C.-F. | Toxicology Letters | 141 | 136 | |
| 2010 | Arsenic inhibits myogenic differentiation and muscle regeneration | Yen Y.-P.; KEH-SUNG TSAI ; Chen Y.-W.; Huang C.-F.; RONG-SEN YANG ; Liu S.-H. | Environmental Health Perspectives | 58 | 57 | |
| 2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
| 2013 | Butyrate induces reactive oxygen species production and affects cell cycle progression in human gingival fibroblasts | Chang M.-C.; YI-LING TSAI ; YI-WEN CHEN ; Chan C.-P.; Huang C.-F.; Lan W.-C.; Lin C.-C.; Lan W.-H.; JIIANG-HUEI JENG | Journal of Periodontal Research | 66 | 62 | |
| 2010 | Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts | Huang C.-F.; Lira C.; Chu K.; Bilen M.A.; Lee Y.-C.; Ye X.; Kim S.M.; Ortiz A.; FE-LIN LIN WU ; Logothetis C.J.; Yu-Lee L.-Y.; Lin S.-H. | Cancer Research | 97 | 87 | |
| 1999 | Characterization of a novel ADP-ribosylation factor-like protein (yARL3) in saccharomyces cerevisiae | Huang C.-F.; Buu L.-M.; Yu W.-L.; Fang-Jen Scott Lee | Journal of Biological Chemistry | 39 | 38 | |
| 2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; Chen C.-Y.; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Leukemia | 52 | 51 | |
| 1997 | Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae | Fang-Jen Scott Lee ; Huang C.-F.; Yu W.-L.; Buu L.-M.; Lin C.-Y.; MIN-CHUAN HUANG ; Moss J.; Vaughan M. | Journal of Biological Chemistry | 73 | 68 | |
| 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; Tsay W.; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 6 | 3 |
